Alterity Therapeutics Limited

ASX (AUD): Alterity Therapeutics Limited (ATH)

Last Price

0.005

Today's Change

+0.001 (25.00%)

Day's Change

0.005 - 0.005

Trading Volume

69,382,625

Overview

Market Cap

26 Million

Shares Outstanding

5 Billion

Avg Volume

6,162,030

Avg Price (50 Days)

0.00

Avg Price (200 Days)

0.00

PE Ratio

-0.50

EPS

-0.01

Earnings Announcement

03-Feb-2025

Previous Close

0.00

Open

0.01

Day's Range

0.005 - 0.005

Year Range

0.002 - 0.008

Trading Volume

69,382,625

Price Change Highlight

1 Day Change

25.00%

5 Day Change

25.00%

1 Month Change

66.67%

3 Month Change

66.67%

6 Month Change

25.00%

Ytd Change

-28.57%

1 Year Change

-28.57%

3 Year Change

-77.27%

5 Year Change

-78.26%

10 Year Change

-97.22%

Max Change

-99.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment